Literature DB >> 12217451

Fatigue in multiple sclerosis: reciprocal relationships with physical disabilities and depression.

Karlein M G Schreurs1, Denise T D de Ridder, Jozien M Bensing.   

Abstract

OBJECTIVE: To explore relations of fatigue, physical disabilities, and depression in patients with multiple sclerosis (MS) cross-sectionally and over time.
METHODS: Ninety-eight MS patients were interviewed twice at an interval of a year. Relationships of physical and mental fatigue, and reduced activity and motivation with depression and physical disabilities were established cross-sectionally by regression analyses and longitudinally by structural equation modelling.
RESULTS: Cross-sectionally, physical fatigue was related with physical disabilities, and mental fatigue was associated with depression. Prospectively, physical fatigue was a predictor of the physical disabilities of a year later. The reverse relationship of physical disabilities predicting the physical fatigue of one year later was, however, not significant, while depression predicted this physical fatigue and reduced activity of a year later. Depression did not predict the later mental fatigue nor was depression predicted by preceding fatigue experiences.
CONCLUSIONS: Fatigue in MS should be studied over time as relationships of fatigue with physical and mental health change during the course of a year. Moreover, differentiating in fatigue experiences sheds light on the relationship of fatigue with physical and mental health. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12217451     DOI: 10.1016/s0022-3999(02)00326-4

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  16 in total

1.  Depression in multiple sclerosis: a longitudinal analysis.

Authors:  Claudia C Beal; Alexa K Stuifbergen; Adama Brown
Journal:  Arch Psychiatr Nurs       Date:  2007-08       Impact factor: 2.218

Review 2.  [Cognitive dysfunctions in multiple sclerosis patients].

Authors:  C Engel; B Greim; U K Zettl
Journal:  Nervenarzt       Date:  2005-08       Impact factor: 1.214

3.  Fatigue in multiple sclerosis persists over time: a longitudinal study.

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

Review 4.  Depression in multiple sclerosis: a review.

Authors:  R J Siegert; D A Abernethy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

5.  Physical and psychological correlates of fatigue and physical function: a Collaborative Health Outcomes Information Registry (CHOIR) study.

Authors:  John A Sturgeon; Beth D Darnall; Ming-Chih J Kao; Sean C Mackey
Journal:  J Pain       Date:  2014-12-20       Impact factor: 5.820

Review 6.  The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases.

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Ken Walder; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-01-20       Impact factor: 5.590

7.  Longitudinal course of depression symptoms in multiple sclerosis.

Authors:  P A Arnett; J J Randolph
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-05       Impact factor: 10.154

Review 8.  Cognitive impairment in multiple sclerosis.

Authors:  Alexander Winkelmann; Claudia Engel; Annett Apel; Uwe K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

9.  "You have to fight to legitimize your existence all the time": The social context of depression in men with physical disabilities.

Authors:  Dena Hassouneh; Kiki Fornero
Journal:  Arch Psychiatr Nurs       Date:  2020-11-26       Impact factor: 2.218

10.  Randomized controlled trial of a teleconference fatigue management plus physical activity intervention in adults with multiple sclerosis: rationale and research protocol.

Authors:  Matthew Plow; Marcia Finlayson; Robert W Motl; Francois Bethoux
Journal:  BMC Neurol       Date:  2012-10-16       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.